Related references
Note: Only part of the references are listed.Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies
H. El-Serag et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care - prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg
A. Eggleston et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
A Randomized, Comparative Trial of a Potassium-Competitive Acid blocker (AZD0865)and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease
John Dent et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Esophageal pH-Impedance Monitoring in Patients With Therapy-Resistant Reflux Symptoms: 'On' or 'Off' Proton Pump Inhibitor?
Gerrit J. M. Hemmink et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
When proton pump inhibitors fail
Peter J. Kahrilas
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors
F. Zerbib et al.
GUT (2008)
Randomized, double-blind, comparative study of dexrabeprazole 10 mg versus rabeprazole 20 mg in the treatment of gastroesophageal reflux disease
Vikas Pai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Comparative clinical trial of S-pantoprazole versus racemic pantoprazole in the treatment of gastro-esophageal reflux disease
Vikas G. Pai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
The montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus
Nimish Vakil et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Maintenance of healed erosive esophagitis: A randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams
Kenneth R. Devault et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease
PJ Kahrilas et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Management of symptoms in step-down therapy of gastroesophageal reflux disease
S Mine et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Assessing symptoms in gastroesophageal reflux disease: How well do clinicians' assessments agree with those of their patients?
E McColl et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease
WM Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis
WJ Bochenek et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Symptom-relieving effect of esomeprazole 40 mg daily in patients with heartburn
F Johnsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis:: Metropole study results
K Lauritsen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis - Results of a multinational study
T Korner et al.
DIGESTION (2003)
Lansoprazole and esomeprazole in symptomatic GERD - A double-blind, randomised, multicentre trial in 3000 patients confirms comparable symptom relief
W Chey et al.
CLINICAL DRUG INVESTIGATION (2003)
A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease
G Holtmann et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
High-dose proton-pump inhibitors as a diagnostic test of gastrooesophageal reflux disease in endoscopic-negative patients
P Juul-Hansen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Comparison of pantoprazole 20 mg to ranitidine 150 mg bid in the treatment of mild gastroesophageal reflux disease
S Kaspari et al.
DIGESTION (2001)
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy - a prospective, randomized, multi-centre study
R Fass et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis
JE Richter et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
